Sarcoma clinical trials in Nebraska

11 actively recruiting sarcoma trials at 9 sites across Nebraska.

Data from ClinicalTrials.gov · last refreshed 2026-04-20

Phase 3 Recruiting NIH

Measuring if Immunotherapy Plus Chemotherapy is Better Than Chemotherapy Alone for Patients With Aggressive Poorly Differentiated Sarcomas

This phase III trial compares the effect of immunotherapy (pembrolizumab) plus chemotherapy (doxorubicin) to chemotherapy (doxorubicin) alone in treating patients with dedifferentiated liposarcoma (DDLPS), undifferentiated pleomorphic sarc…

Sponsor: National Cancer Institute (NCI)

NCT ID: NCT06422806

Sites in Nebraska:

Nebraska Medicine-Bellevue — Bellevue, Nebraska
Nebraska Medicine-Village Pointe — Omaha, Nebraska
University of Nebraska Medical Center — Omaha, Nebraska

View on ClinicalTrials.gov →

Phase 3 Recruiting Network

Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma

This phase III trial compares the effect of open thoracic surgery (thoracotomy) to thoracoscopic surgery (video-assisted thoracoscopic surgery or VATS) in treating patients with osteosarcoma that has spread to the lung (pulmonary metastase…

Sponsor: Children's Oncology Group

NCT ID: NCT05235165

Sites in Nebraska:

Children's Hospital and Medical Center of Omaha — Omaha, Nebraska
University of Nebraska Medical Center — Omaha, Nebraska

View on ClinicalTrials.gov →

Phase 2, Phase 3 Recruiting NIH

A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma

This phase II/III trial tests the safety, side effects, and best dose of the drug cabozantinib in combination with standard chemotherapy, and to compare the effect of adding cabozantinib to standard chemotherapy alone in treating patients …

Sponsor: National Cancer Institute (NCI)

NCT ID: NCT05691478

Sites in Nebraska:

Children's Hospital and Medical Center of Omaha — Omaha, Nebraska
University of Nebraska Medical Center — Omaha, Nebraska

View on ClinicalTrials.gov →

Phase 3 Recruiting Network

Chemotherapy for the Treatment of Patients With Newly Diagnosed Very Low-Risk and Low Risk Fusion Negative Rhabdomyosarcoma

Rhabdomyosarcoma is a type of cancer that occurs in the soft tissues in the body. This phase III trial aims to maintain excellent outcomes in patients with very low risk rhabdomyosarcoma (VLR-RMS) while decreasing the burden of therapy usi…

Sponsor: Children's Oncology Group

NCT ID: NCT05304585

Sites in Nebraska:

Children's Hospital and Medical Center of Omaha — Omaha, Nebraska
University of Nebraska Medical Center — Omaha, Nebraska

View on ClinicalTrials.gov →

Phase 3 Recruiting Network

Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sarcoma

This is a multicenter, randomized, open label phase lll trial to assess whether preoperative chemotherapy, as an adjunct to curative-intent surgery, improves the prognosis of high risk DDLPS (dedifferentiated Liposarcoma) and LMS (Leiomyos…

Sponsor: European Organisation for Research and Treatment of Cancer - EORTC

NCT ID: NCT04031677

Sites in Nebraska:

Nebraska Medicine-Bellevue — Bellevue, Nebraska
Nebraska Medicine-Bellevue — Omaha, Nebraska
University of Nebraska Medical Center — Omaha, Nebraska

View on ClinicalTrials.gov →

Phase 3 Recruiting Academic/Other

Impact of Sentinel Lymph Node Mapping on Patient Reported Lower Extremity Limb Dysfunction in Stage I Endometrial Cancer

This phase III trial compares the effect of sentinel lymph node mapping to standard lymph node dissection in reducing the risk of swelling in the legs (lymphedema) in patients undergoing a hysterectomy for stage I endometrial cancer. Stand…

Sponsor: NRG Oncology

NCT ID: NCT05646316

Sites in Nebraska:

Fred and Pamela Buffett Cancer Center - Kearney — Kearney, Nebraska
Nebraska Medicine-Village Pointe — Omaha, Nebraska
Alegent Health Bergan Mercy Medical Center — Omaha, Nebraska
University of Nebraska Medical Center — Omaha, Nebraska

View on ClinicalTrials.gov →

Phase 1, Phase 2 Recruiting Industry

Lead-212 PSV359 Therapy for Patients With Solid Tumors

Phase I/IIa image-guided, alpha-particle therapy study of \[203Pb\]Pb-PSV359 and \[212Pb\]Pb-PSV359 in patients with solid tumors that are known to be Fibroblast Activation Protein (FAP)-positive.

Sponsor: Perspective Therapeutics

NCT ID: NCT06710756

Sites in Nebraska:

Nebraska Cancer Specialists — Omaha, Nebraska

View on ClinicalTrials.gov →

Phase 2 Recruiting Academic/Other

CAR-T Followed by Bispecific Antibodies

The research study is being conducted to test the safety and effectiveness of the experimental drug mosunetuzumab (Cohort 1) or obinutuzumab and glofitamab (Cohort 2) when given after CAR (genetically modified) T cells. The study is for pa…

Sponsor: Abramson Cancer Center at Penn Medicine

NCT ID: NCT04889716

Sites in Nebraska:

University of Nebraska Medical Center — Omaha, Nebraska

View on ClinicalTrials.gov →

Recruiting Academic/Other

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

This study collects blood and tissue samples from patients with cancer and without cancer to evaluate tests for early cancer detection. Collecting and storing samples of blood and tissue from patients with and without cancer to study in th…

Sponsor: Alliance for Clinical Trials in Oncology

NCT ID: NCT05334069

Sites in Nebraska:

CHI Health Saint Francis — Grand Island, Nebraska
Nebraska Cancer Specialists/Oncology Hematology West PC — Grand Island, Nebraska
CHI Health Good Samaritan — Kearney, Nebraska
Saint Elizabeth Regional Medical Center — Lincoln, Nebraska
Alegent Health Immanuel Medical Center — Omaha, Nebraska

View on ClinicalTrials.gov →

NA Recruiting Network

Improving Adolescent and Young Adult Self-Reported Data in ECOG-ACRIN Trials

The purpose of this study is to evaluate feasibility and acceptability of completing PROs among AYAs randomized to Choice PRO vs Fixed PRO.

Sponsor: Eastern Cooperative Oncology Group

NCT ID: NCT05108298

Sites in Nebraska:

Nebraska Cancer Specialists/Oncology Hematology West PC — Grand Island, Nebraska
CHI Health Good Samaritan — Kearney, Nebraska
Saint Elizabeth Regional Medical Center — Lincoln, Nebraska
Alegent Health Immanuel Medical Center — Omaha, Nebraska
Alegent Health Bergan Mercy Medical Center — Omaha, Nebraska

View on ClinicalTrials.gov →

Recruiting Academic/Other

Integrated Cancer Repository for Cancer Research

The iCaRe2 is a multi-institutional resource created and maintained by the Fred \& Pamela Buffett Cancer Center to collect and manage standardized, multi-dimensional, longitudinal data and biospecimens on consented adult cancer patients, h…

Sponsor: University of Nebraska

NCT ID: NCT02012699

Sites in Nebraska:

Mary Lanning Healthcare, Morrison Cancer Center — Hastings, Nebraska
Faith Regional Health Services, Carson Cancer Center — Norfolk, Nebraska
Great Plains Regional Medical Center — North Platte, Nebraska
Methodist Estabrook Cancer Center — Omaha, Nebraska
Nebraska Methodist Health System — Omaha, Nebraska

View on ClinicalTrials.gov →

Medical disclaimer: This page aggregates public ClinicalTrials.gov data. It is not medical advice. Always confirm eligibility and enrollment details with the trial site or your oncologist.

Source: ClinicalTrials.gov API v2 · Last checked: 2026-04-20